Latest MagVenture News & Updates
See the latest news and media coverage for MagVenture. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of transcranial magnetic stimulation systems
magventure.com- Headquarters
- Farum, Denmark
- Founded year
- 1992
- Company type
- Private company
- Number of employees
- 200–500
Latest news about MagVenture
Company announcements
-
MagVenture announces Lancet Psychiatry publication of MST trial results
The large randomized trial shows MST is non-inferior to ECT for depression remission with better cognitive safety. It involved 236 participants.
-
SLMANA donates TMS systems to Sri Lankan hospitals
The donation brings non-invasive depression treatment to underserved regions in Colombo and Jaffna, including training for long-term impact.
-
MagVenture introduces MagVenture Universe
The all-in-one resource hub offers TMS training videos, insurance guides, and marketing materials for customers.
-
MagVenture acquires Brain Science Tools
The acquisition enhances neuronavigation for TMS, integrates BST's expertise into R&D, and advances the ATLAS platform.
Media coverage
-
Large confirmatory clinical trial shows efficacy and safety of new brain stimulation therapy for depression
A landmark international clinical trial led by researchers at the Centre for Addiction and Mental Health (CAMH) and University of California San Diego School of...
-
A phase I trial of accelerated intermittent theta burst rTMS for amnestic MCI
Background Emerging evidence suggests that repetitive transcranial magnetic stimulation (rTMS) enhances cognition in mild cognitive impairment (MCI). Accelerated intermittent theta burst stimulation (iTBS) rTMS protocols...
-
FDA Expands MagVenture TMS Indications to Treat MDD, OCD, and Anxious Depression with One Coil
With this expanded portfolio, our users can now choose the most appropriate coil for each specific patient, prioritizing comfort, treatment precision, and outcomes." — Kerry...
-
MagVenture Receives FDA Clearance to Expand TMS Therapy Indication for Adolescents Aged 15-21
ALPHARETTA, GA, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- MagVenture, the global leader of non-invasive TMS neuromodulation technology, announced today ...
Track MagVenture and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO